NCT00000778View on ClinicalTrials.gov

A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Conditions

HIV InfectionsTuberculosis

Interventions

DRUG

Isoniazid

DRUG

Pyridoxine hydrochloride

DRUG

Levofloxacin

Trial Locations (10)

33136

Univ of Miami / Jackson Memorial Hosp, Miami

33316

Broward Gen Med Ctr, Fort Lauderdale

60622

Univ of Illinois, Chicago

75235

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

77030

Baylor College of Medicine / Houston Veterans Adm Med Ctr, Houston

77550

Univ TX Galveston, Galveston

90502

Harbor - UCLA Med Ctr, Torrance

352336505

Univ of Alabama at Birmingham, Birmingham

701122699

Tulane Univ Med School, New Orleans

900951793

UCLA Med Ctr, Los Angeles

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000778 - A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin | Biotech Hunter | Biotech Hunter